§ Funding Round
Series B funding round for Engrail Therapeutics raising $160M in March 2024
Series B funding round for Engrail Therapeutics raising $160M in March 2024
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
| Organization | — | |
ForbionLEAD | Organization | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Angel | ed mathers | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
stacie weningerLEAD | Angel | stacie weninger |
| Organization | — | |
tiba aynechiLEAD | Angel | tiba aynechi |
| Angel | peter bisgaard | |
Niall O'Donnell | — | — |
| Angel | guillem laporta, cfa |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$224M
Top Valuation
-
Engrail Therapeutics raised $160M in a Series B round.
The round was announced on 03/01/24.
The round was led by Forbion, stacie weninger, tiba aynechi.
